Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership9,204 shares
Latest Disclosed Value $ 32,306
Group One Trading, L.p. ownership in 9IP1 / Rocket Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 9,204 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $25,348 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 15,484 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -40.56% during the quarter. The current value of the position is $22,458 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (9IP1) in the form of stock options. The firm currently holds call options representing 36,900 of underlying shares valued at $129,519 USD and put options representing 1,600 of underlying shares valued at $5,616 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9IP1 / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 9,204 -6,280 -40.56 32 -36.00 0.0001
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 15,484 -50,014 -76.36 50 -68.75 0.0001
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 65,498 64,414 5,942.25 160 2,185.71 0.0004
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,084 1,084 7 0.0000
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -6,331 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 6,331 6,331 136 0.0005
2023-02-09 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -200 -100.00 0 -100.00
2022-11-09 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 200 200 3 0.0000
2022-08-11 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -88 -100.00 0 -100.00
2022-05-12 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 88 88 1 0.0000
2020-05-12 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -501 -100.00 0 -100.00
2020-02-10 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 501 501 11 0.0001
2019-08-09 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -1,999 -100.00 0 -100.00
2019-05-14 2019-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 1,999 1,017 103.56 35 133.33 0.0004
2019-05-13 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,999 1,017 35
2019-02-05 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 982 -28 -2.77 15 -40.00 0.0001
2018-11-08 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,010 1,010 25 0.0002
2018-08-13 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -55 -100.00 0 -100.00
2018-05-16 2018-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 55 -2,663 -97.98 1 -85.71 0.0000
2018-05-10 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 55 1
2018-02-09 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,718 -13,204 -82.93 7 -75.00 0.0000
2017-11-15 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 15,922 -10,396 -39.50 28 -44.00 0.0003
2017-08-14 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 26,318 23,617 874.38 50 900.00 0.0005
2017-05-10 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,701 401 17.43 5 -64.29 0.0001
2017-02-15 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,300 1,000 76.92 14 16.67 0.0001
2016-11-14 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 1,300 1,300 12 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS COM Call 36,900 -79.67 130 -78.17 n/a n/a n/a
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM Call 181,500 261.55 592 384.43 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Call 50,200 -0.59 123 -63.69 n/a n/a n/a
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM Call 50,500 653.73 337 300.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ROCKET PHARMACEUTICALS COM Call 6,700 -53.79 84 -68.54 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Call 6,700 84 n/a n/a n/a
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM Call 14,500 -42.91 268 -51.10 n/a n/a n/a
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM Call 25,400 -74.37 547 -79.54 n/a n/a n/a
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM Call 99,100 112.21 2,670 90.78 n/a n/a n/a
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM Call 46,700 -42.35 1,400 -15.67 n/a n/a n/a
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS COM Call 81,000 247.64 1,660 259.09 n/a n/a n/a
2023-08-09 2023-06-30 13F ROCKET PHARMACEUTICALS COM Call 23,300 34.68 463 56.08 n/a n/a n/a
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM Call 17,300 118.99 296 92.21 n/a n/a n/a
2023-02-09 2022-12-31 13F ROCKET PHARMACEUTICALS COM Call 7,900 -53.80 155 -43.59 n/a n/a n/a
2022-11-09 2022-09-30 13F ROCKET PHARMACEUTICALS COM Call 17,100 44.92 273 68.52 n/a n/a n/a
2022-08-11 2022-06-30 13F ROCKET PHARMACEUTICALS COM Call 11,800 162 n/a n/a n/a
2022-05-11 2022-03-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ROCKET PHARMACEUTICALS COM Call 100 -66.67 2 -77.78 n/a n/a n/a
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS COM Call 300 -99.00 9 -99.32 n/a n/a n/a
2021-08-10 2021-06-30 13F ROCKET PHARMACEUTICALS COM Call 29,900 339.71 1,324 338.41 n/a n/a n/a
2021-05-12 2021-03-31 13F ROCKET PHARMACEUTICALS COM Call 6,800 -35.24 302 -47.57 n/a n/a n/a
2021-02-10 2020-12-31 13F ROCKET PHARMACEUTICALS COM Call 10,500 -61.68 576 -7.99 n/a n/a n/a
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM Call 27,400 37.00 626 49.40 n/a n/a n/a
2020-08-13 2020-06-30 13F ROCKET PHARMACEUTICALS COM Call 20,000 419 n/a n/a n/a
2020-05-12 2020-03-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F ROCKET PHARMACEUTICALS COM Call 4,000 91 n/a n/a n/a
2018-11-08 2018-09-30 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ROCKET PHARMACEUTICALS COM Call 900 -55.00 18 -52.63 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ROCKET PHARMACEUTICALS COM Call 2,000 -86.67 38 -2.56 n/a n/a n/a
2018-05-10 2018-03-31 13F ROCKET PHARMACEUTICALS COM Call 2,000 38 n/a n/a n/a
2018-02-09 2017-12-31 13F INOTEK PHARMACEUTICALS COM Call 15,000 15.38 39 69.57 n/a n/a n/a
2017-11-15 2017-09-30 13F INOTEK PHARMACEUTICALS COM Call 13,000 -50.19 23 -55.77 n/a n/a n/a
2017-05-10 2017-03-31 13F INOTEK PHARMACEUTICALS COM Call 26,100 -37.41 52 -79.53 n/a n/a n/a
2017-02-15 2016-12-31 13F INOTEK PHARMACEUTICALS COM Call 41,700 254 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS COM Put 1,600 -78.95 6 -79.17 n/a n/a n/a
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM Put 7,600 123.53 25 200.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Put 3,400 -84.62 8 -94.56 n/a n/a n/a
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM Put 22,100 176.25 147 47.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ROCKET PHARMACEUTICALS COM Put 8,000 280.95 101 163.16 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Put 8,000 101 n/a n/a n/a
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM Put 2,100 -88.65 39 -90.45 n/a n/a n/a
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM Put 18,500 172.06 398 117.49 n/a n/a n/a
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM Put 6,800 -75.45 183 -77.95 n/a n/a n/a
2024-02-14 2023-12-31 13F ROCKET PHARMACEUTICALS COM Put 27,700 2,418.18 830 3,672.73 n/a n/a n/a
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS COM Put 1,100 120.00 23 144.44 n/a n/a n/a
2023-08-09 2023-06-30 13F ROCKET PHARMACEUTICALS COM Put 500 150.00 10 200.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM Put 200 100.00 3 200.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ROCKET PHARMACEUTICALS COM Put 100 2 n/a n/a n/a
2022-05-11 2022-03-31 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ROCKET PHARMACEUTICALS COM Put 100 2 n/a n/a n/a
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ROCKET PHARMACEUTICALS COM Put 10,800 -46.53 478 -46.65 n/a n/a n/a
2021-05-12 2021-03-31 13F ROCKET PHARMACEUTICALS COM Put 20,200 80.36 896 45.93 n/a n/a n/a
2021-02-10 2020-12-31 13F ROCKET PHARMACEUTICALS COM Put 11,200 160.47 614 526.53 n/a n/a n/a
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM Put 4,300 98 n/a n/a n/a
2020-05-12 2020-03-31 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F ROCKET PHARMACEUTICALS COM Put 6,000 137 n/a n/a n/a
2018-05-16 2018-03-31 13F/A INOTEK PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F INOTEK PHARMACEUTICALS COM Put 9,000 23 n/a n/a n/a
2017-11-14 2017-09-30 13F INOTEK PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F INOTEK PHARMACEUTICALS COM Put 15,000 -6.25 29 -9.37 n/a n/a n/a
2017-05-10 2017-03-31 13F INOTEK PHARMACEUTICALS COM Put 16,000 -29.82 32 -76.98 n/a n/a n/a
2017-02-15 2016-12-31 13F INOTEK PHARMACEUTICALS COM Put 22,800 22,700.00 139 13,800.00 n/a n/a n/a
2016-11-14 2016-09-30 13F INOTEK PHARMACEUTICALS COM Put 100 0.00 1 0.00 n/a n/a n/a
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM Put 100 0.00 1 0.00 n/a n/a n/a
2016-05-12 2016-03-31 13F INOTEK PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.